Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleic acid methylation refers to the addition of a methyl group to nucleic acids, primarily DNA and RNA. This chemical modification, catalyzed by methyltransferases, plays a critical role in regulating gene expression, maintaining genome stability, and controlling cellular differentiation. Aberrant methylation patterns are associated with various diseases, particularly cancer, making it a target for epigenetic therapies.
Inhibition or modulation of DNA methyltransferases
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleic Acid Methylation.